Incidence and the risk factor of malignancy in Japanese patients with systemic sclerosis.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Internal medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.2169/INTERNALMEDICINE.51.7686PMID 22790126
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical features of 405 Japanese patients with systemic sclerosis

  2012cited by this paper
• Malignancies in Italian Patients with Systemic Sclerosis Positive for Anti-RNA Polymerase III Antibodies

  2011cited by this paper
• Predictors of Survival and Causes of Death in Japanese Patients with Systemic Sclerosis

  2011cited by this paper
• Close temporal relationship between onset of cancer and scleroderma in patients with RNA polymerase I/III antibodies.

  2010cited by this paper
• Systemic sclerosis and the risk of cancer: a nationwide population‐based cohort study

  2010cited by this paper
• Incidence of cancer among patients with systemic sclerosis in Korea: results from a single centre

  2009cited by this paper
• Changes in causes of death in systemic sclerosis, 1972–2002

  2007cited by this paper
• A cohort study of cancer incidence in systemic sclerosis.

  2006cited by this paper
• Risk factors for lung cancer in patients with scleroderma: a nested case–control study

  2006cited by this paper
• Risk of malignancy in scleroderma: a population-based cohort study.

  2005cited by this paper
• Does interstitial lung disease predispose to lung cancer?

  2005cited by this paper
• Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

  2005cited by this paper
• The risk of lymphoma development in autoimmune diseases: a meta-analysis.

  2005cited by this paper
• The epidemiology of interstitial lung disease and its association with lung cancer

  2004cited by this paper
• Cancer incidence and incidence rates in Japan in 1999: estimates based on data from 11 population-based cancer registries.

  2004cited by this paper
• Revised Japanese criteria for Sjögren's syndrome (1999): availability and validity

  2004cited by this paper
• Risk of cancer in patients with scleroderma: a population based cohort study

  2003cited by this paper
• Age and risk of pulmonary arterial hypertension in scleroderma.

  2003cited by this paper
• A Statistical Study of Lung Cancer in the Annual of Pathological Autopsy Cases in Japan, from 1958 to 1997, with Reference to Time Trends of Lung Cancer in the World

  2002cited by this paper
• Lung cancer associated with several connective tissue diseases: with a review of literature

  2001cited by this paper
• Cancer incidence and incidence rates in Japan in 1996: estimates based on data from 10 population-based cancer registries.

  2001cited by this paper
• Anticentromere Antibody as a Risk Factor for Cancer in Patients with Systemic Sclerosis

  2000cited by this paper
• Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study.

  2000cited by this paper
• Does idiopathic pulmonary fibrosis increase lung cancer risk?

  2000cited by this paper
• Cancer incidence in Japan in 1990: estimates based on data from Population-based Cancer Registries. The Research Group for Population-based Cancer Registration in Japan.

  1998cited by this paper
• Gastrointestinal manifestations of scleroderma.

  1998cited by this paper
• Cancer incidence in Japan, 1985-89: re-estimation based on data from eight population-based cancer registries. The Research Group for Population-based Cancer Registration in Japan.

  1998cited by this paper
• Epidemiological Analysis of Prognosis of 496 Japanese Patients with Progressive Systemic Sclerosis (SSc)

  1996cited by this paper
• Iung cancer associated with usual interstitial pneumonia

  1995cited by this paper
• [Progressive systemic sclerosis (PSS) and cancer--increasing coincidence rate of cancer in 67 PSS patients].

  1995cited by this paper
• Incidence of cancer among patients with systemic sclerosis

  1995cited by this paper
• Cancer in systemic sclerosis.

  1993cited by this paper
• Scleroderma and malignancy: an epidemiological study.

  1993cited by this paper
• Japanese diagnostic criteria for mixed connective tissue disease in Caucasian patients.

  1992cited by this paper
• Association of anti-topoisomerase I with cancer.

  1992cited by this paper
• Revised criteria for the classification of rheumatoid arthritis.

  1990cited by this paper
• Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.

  1988cited by this paper
• The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

  1988cited by this paper
• A survival study of patients with scleroderma diagnosed over 30 years (1953-1983): the value of a simple cutaneous classification in the early stages of the disease.

  1988cited by this paper
• Barrett's metaplasia and adenocarcinoma of the esophagus in scleroderma.

  1987cited by this paper
• Incidence of lung cancer in systemic sclerosis.

  1985cited by this paper
• Cancer and systemic sclerosis. An epidemiologic study.

  1985cited by this paper
• Factors predicting development of renal involvement in progressive systemic sclerosis.

  1984cited by this paper
• The 1982 revised criteria for the classification of systemic lupus erythematosus.

  1982cited by this paper
• Cancer in connective tissue disease.

  1982cited by this paper
• Cryptogenic fibrosing alveolitis and lung cancer.

  1980cited by this paper
• Cancer and scleroderma.

  1979cited by this paper
• SCLERODERMA: 1. CLINICAL FEATURES, COURSE OF ILLNESS AND RESPONSE TO TREATMENT IN 61 CASES

  1969cited by this paper

• Neoplasm related mortality risk in Systemic Sclerosis: a nationwide study

  2025cites this paper
• Current pharmacotherapies for advanced lung cancer with pre-existing interstitial lung disease : A literature review and future perspectives.

  2024cites this paper
• Preventative Care in Scleroderma: What Is the Best Approach to Bone Health and Cancer Screening?

  2023cites this paper
• Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: Data from the Spanish Scleroderma Registry (RESCLE).

  2022cites this paper
• Increased malignancies in our Waikato cohort of patients with systemic sclerosis

  2021cites this paper
• The risk of cancer in patients with primary Sjögren syndrome: a single-center study from Turkey

  2021cites this paper
• Clinical and Pathological Features of Breast Cancer in Systemic Sclerosis: Results from the Sclero-Breast Study

  2021cites this paper
• Advances at the interface of cancer and systemic sclerosis

  2020cites this paper
• Cancer risk in systemic sclerosis: identifying risk and managing high-risk patients

  2020cites this paper
• Cancer and Scleroderma.

  2020cites this paper
• Biphasic Temporal Relationship between Cancers and Systemic Sclerosis: A Clinical Series from Montpellier University Hospital and Review of the Literature

  2020cites this paper
• Endoscopic Features of Upper Gastrointestinal Tract in Patients with Systemic Sclerosis Compared to the Healthy Control

  2019cites this paper
• [Cancers in systemic sclerosis : risk factors, impact on survival and literature review].

  2019cites this paper
• Summary of the Japanese Respiratory Society statement for the treatment of lung cancer with comorbid interstitial pneumonia.

  2019cites this paper
• Lung cancer and interstitial lung disease: a literature review.

  2018cites this paper
• Survenue de cancer au cours de la sclérodermie systémique : facteurs de risque et impact sur la survie avec revue de la littérature

  2018cites this paper
• Gastrointestinal manifestations associated with systemic sclerosis: results from the nationwide inpatient sample

  2017cites this paper
• Novel risk factors related to cancer in scleroderma.

  2017cites this paper
• Mechanistic and clinical insights at the scleroderma-cancer interface

  2017cites this paper
• Barrett’s Esophageal Adenocarcinoma with CREST Syndrome

  2017cites this paper
• Risk factors for malignancy in systemic sclerosis patients

  2016cites this paper
• Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature

  2015cites this paper
• Squamous Cell Lung Cancer Associated With Systemic Sclerosis

  2015cites this paper
• Breast cancer in systemic sclerosis: results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature.

  2014cites this paper
• Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma

  2014cites this paper
• Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies.

  2013cites this paper
• The risk of cancer development in systemic sclerosis: a meta-analysis.

  2013cites this paper